Global Kidney Function Tests Market - 2023-2030

Global Kidney Function Tests Market - 2023-2030

The Global Kidney Function Tests Market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 1.4 billion by 2030. The market is expected to exhibit a CAGR of 6.3% during the forecast period 2023-2030.

Kidney function tests identify kidney or renal function disorders and assist doctors in prescribing appropriate medicine. Dilution tests, clearance tests and other types of kidney function tests are available. Kidney diseases such as trouble urinating due to excess bodily fluids, edema in the hands or feet, and swollen face can be identified using a kidney function test.

The factors driving the growth of the market include FDA approvals and the launch of new products by the key players for kidney function tests. For instance, on July 12, 2022, Healthy.io, the global pioneer in integrating the smartphone camera into a medical device, announced that the Minuteful Kidney test has acquired 510(k) clearance from the US Food and Drug Administration (FDA) for home use.

Market Dynamics

Increasing the Prevalence of Kidney Diseases will Drive the Kidney Function Tests Market Growth

The global rise in the incidence and prevalence of chronic kidney disease is a major factor driving the growth of the global kidney function testing market. For instance, according to NIDDK 2021, Chronic kidney disease (CKD) affects more than one in every seven adults in the United States, totaling an estimated 37 million people.

The risk of CKD is even higher for Americans who have diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of people with diabetes and one-fifth of people with high blood pressure.

Additionally, according to the Centers for Disease Control and Prevention’s (CDC) Chronic Kidney Disease in the United States, 2021, CKD is slightly more prevalent in women (14%) than in men (12%), and it is more common in non-Hispanic Black adults (16%) than in non-Hispanic white adults (13%) or non-Hispanic Asian people (13%). Thus, the frequency of CKD will fuel market expansion.

High Diagnostic Process Costs are Expected to Hamper the Market Growth

The high cost of kidney function tests, as well as the low acceptance rate in emerging and developing nations, will stifle market expansion. The increased number of people with a clinical diagnosis of kidney disease as a result of the modified formula means that more people may receive recommendations for dose adjustments or contraindications for certain drugs that may interfere with kidney function or be poorly filtered by the kidneys.

COVID-19 Impact Analysis

The pandemic of COVID-19 has had a moderate impact on healthcare systems and the market. According to a study published in medRXiv in April 2020, COVID-19 urine incontinence was often observed in persons with a variety of infectious and harmful illnesses. Children aged 0 to 12 who have a little light type of COVID-19 have been found to have urinary tract COVID-19 exposure.

COVID-19 urinary tract infections were identified between the first and fifth days after the disease's onset. Kidney function markers are used to determine how well the kidneys function. Some signals are radioactive as well as non-radioactive. They demonstrate the kidneys' glomerular filtration rate as well as their concentrating and diluting capacities (tubular function). Many people would rather buy a kidney function test at a store than online.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global kidney function tests market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products and devices is anticipated to have little influence over the global kidney function tests market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global preeclampsia market positively. Artificial intelligence-powered decision support systems can help healthcare personnel make well-informed judgements about renal diagnosis and treatment options. These systems are capable of analyzing patient data, comparing it to current medical knowledge and making suggestions based on evidence-based guidelines. This assists doctors in selecting the best diagnostic tests, drugs or actions for particular patients.

Segment Analysis

The global kidney function tests market is segmented based on product type, test type end user and region.

The Dipstick Segment is Estimated to Hold the Majority of the Kidney Function Tests Market Share During the Forecast Period

The Dipstick product type holds about 47.3% of the total kidney function tests market in the forecast period. Dipstick tests provide rapid results, usually within a few minutes, allowing for immediate assessment of kidney health. They are easy to use and do not require extensive laboratory equipment or specialized training, making them accessible in various healthcare settings, including clinics, emergency rooms and home.

This aids in the diagnosis of a variety of renal and urinary issues, including chronic kidney disease, bladder infections and kidney stones. Furthermore, the increasing number of people and important companies' strategies in renal function testing promote some growth.

For instance, Sweden's Elypta AB raised USD 7.0 million in January 2020 for a urine cancer screening test. Therefore, a patient's urine can reveal a lot of information about their health, increasing the use of dipsticks. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America Holds a Dominant Position in the Global Kidney Function Tests Market

The North American region holds the second-largest share of the global kidney function tests market accounting for approximately 39.4% in the forecast period. Due to well-established healthcare infrastructure, widespread awareness of CKD and favorable reimbursement policies and government initiatives. Furthermore, the region's main manufacturers are focused on inventing innovative products.

For instance, Abbott HealthTab signed a non-assignable, pilot supplier distribution agreement with Abbott in November 2021 for i-STAT Alinity, a handheld blood chemistry analyzer. The partnership allows HealthTab to sell Abbott's POC i-STAT Alinity and associated creatinine tests in Canadian pharmacies, providing patients with important information regarding their kidney functioning.

Competitive Landscape

The major global players in the market include F. Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMérieux SA, OPTI Medical, Siemens Healthineers. among others.

Why Purchase the Report?
• To visualize the global kidney function tests market segmentation based on product type, test type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of kidney function tests market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.

The Global Kidney Function Tests Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.

Target Audience 2023
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies